{"id":"W3106551357","doi":"10.1093/europace/euaa199","title":"Periprocedural anticoagulation in the uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation (ELIMINATE-AF) trial","year":2020,"lang":"en","type":"article","venue":"EP Europace","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"Libin Cardiovascular Institute of Alberta; University of Calgary","funders":"Bayer Vital; St. Jude Medical; Pfizer; Bracco Imaging; Daiichi Sankyo Europe; Sanofi; European Commission; Deutsche Gesellschaft für Neurologie; Daiichi-Sankyo; Bundesministerium für Bildung und Forschung; Deutsche Forschungsgemeinschaft; Servier; Biosense Webster; National Institutes of Health; Boston Scientific Corporation","keywords":"Medicine; Edoxaban; Atrial fibrillation; Activated clotting time; Vitamin K antagonist; Catheter ablation; Internal medicine; Cardiology; Ablation; Anesthesia; Warfarin; Heparin; Dabigatran","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003892128,0.0001443547,0.0003230909,0.000114138,0.00006904436,0.0000354253,0.00008225478,0.00006642428,0.00003226132],"category_scores_gemma":[0.0009261457,0.0001123861,0.0002287144,0.0004332482,0.00004322601,0.000160164,0.00002708743,0.00008197752,0.00001082076],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003513904,"about_ca_system_score_gemma":0.00004387625,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000145858,"about_ca_topic_score_gemma":0.000005339617,"domain_scores_codex":[0.9986706,0.0001333802,0.0004965268,0.0002342357,0.0003025702,0.0001627135],"domain_scores_gemma":[0.9991885,0.0002497656,0.00025696,0.000153328,0.0001046051,0.00004677799],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.4152769,0.00007981985,0.4320893,0.0021605,0.000421756,0.000042372,0.02619205,0.01196042,0.05118225,0.01122288,0.007872694,0.04149899],"study_design_scores_gemma":[0.1281707,0.006155834,0.5735514,0.0001827292,0.0007376433,0.00001651167,0.00179978,0.1751482,0.004829736,0.0001720271,0.1086334,0.000602093],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9726884,0.00007905419,0.002704677,0.02122043,0.0004172252,0.002292828,0.000009506364,0.0000579041,0.0005299886],"genre_scores_gemma":[0.9965474,0.0000272143,0.0005446616,0.0002374684,0.00218457,0.000001940754,0.0001614781,0.00002254536,0.0002727222],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2871063,"threshold_uncertainty_score":0.4582973,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07810344085779422,"score_gpt":0.3446748609192762,"score_spread":0.2665714200614819,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}